T0	Outcomes 632 678	area under the plasma concentration-time curve
T1	Outcomes 705 729	terminal-phase half-life
T2	Outcomes 808 873	magnitude of the reduction in the intrinsic clearance of caffeine
T3	Outcomes 1133 1161	pharmacokinetics of caffeine
T4	Outcomes 1242 1267	methylxanthine clearance.